Duchenne Muscular Dystrophy: Modern Approaches in Patient Management
Duchenne muscular dystrophy is one of the most common forms of childhood muscular dystrophies. Its incidence is 1 in 3.5–6 thousand newborn boys according to various sources. The disease is caused by the mutation in the DMD gene coding the dystrophin protein, it leads to the dystrophin absence or ma...
Saved in:
Similar Items
-
Identification of patients with orfan pathology as a result of routine creatine phosphokinase level analysis. The experience of the Krasnoyarsk Territory
by: E. V. Shishkina
Published: (2024-04-01) -
Adequate managment of patients with dystrophinopathies (muscular dystrophy Duchenne/Becker): objective scales and additional diagnostic methods
by: A. S. Nosko, et al.
Published: (2015-02-01) -
THE ROLE OF SELENIUM PREPARATIONS AND VITAMIN E IN NUTRITIONAL MYODYSTROPHY (WHITE MUSCLE DISEASE) IN SHEEP
by: Stancu, A
Published: (2017-06-01) -
The concept of “ambulatory” and “non-ambulatory” in patients with Duchenne muscular dystrophy: definitions and criteria
by: T. A. Gremyakova, et al.
Published: (2022-06-01) -
Immunomodulating effects of tofizopam (Grandaxin®) and diazepam in vitro
by: Sergey V. Kalashnikov, et al.
Published: (2002-01-01)